OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Ex vivo cultures and drug testing of primary acute myeloid leukemia samples: Current techniques and implications for experimental design and outcome
David G. J. Cucchi, Richard W.J. Groen, Jeroen J.W.M. Janssen, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100730-100730
Open Access | Times Cited: 31
David G. J. Cucchi, Richard W.J. Groen, Jeroen J.W.M. Janssen, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100730-100730
Open Access | Times Cited: 31
Showing 1-25 of 31 citing articles:
TET2-mediated mRNA demethylation regulates leukemia stem cell homing and self-renewal
Yangchan Li, Meilin Xue, Xiaolan Deng, et al.
Cell stem cell (2023) Vol. 30, Iss. 8, pp. 1072-1090.e10
Closed Access | Times Cited: 42
Yangchan Li, Meilin Xue, Xiaolan Deng, et al.
Cell stem cell (2023) Vol. 30, Iss. 8, pp. 1072-1090.e10
Closed Access | Times Cited: 42
Overcoming Chemotherapy Resistance in Metastatic Cancer: A Comprehensive Review
Maryam Eslami, Omid Memarsadeghi, Ali Davarpanah, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 183-183
Open Access | Times Cited: 29
Maryam Eslami, Omid Memarsadeghi, Ali Davarpanah, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 183-183
Open Access | Times Cited: 29
Epigenetic enzyme mutations as mediators of anti-cancer drug resistance
Sihong Chen, Yingxi Zhao, Shougeng Liu, et al.
Drug Resistance Updates (2022) Vol. 61, pp. 100821-100821
Closed Access | Times Cited: 33
Sihong Chen, Yingxi Zhao, Shougeng Liu, et al.
Drug Resistance Updates (2022) Vol. 61, pp. 100821-100821
Closed Access | Times Cited: 33
Understanding ER homeostasis and the UPR to enhance treatment efficacy of acute myeloid leukemia
Martyna Śniegocka, Francesca Liccardo, Francesco Fazi, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100853-100853
Open Access | Times Cited: 26
Martyna Śniegocka, Francesca Liccardo, Francesco Fazi, et al.
Drug Resistance Updates (2022) Vol. 64, pp. 100853-100853
Open Access | Times Cited: 26
Phosphoproteomics of primary AML patient samples reveals rationale for AKT combination therapy and p53 context to overcome selinexor resistance
Kristina B. Emdal, Nicolàs Palacio-Escat, Caroline Wigerup, et al.
Cell Reports (2022) Vol. 40, Iss. 6, pp. 111177-111177
Open Access | Times Cited: 26
Kristina B. Emdal, Nicolàs Palacio-Escat, Caroline Wigerup, et al.
Cell Reports (2022) Vol. 40, Iss. 6, pp. 111177-111177
Open Access | Times Cited: 26
Interdisciplinary Approaches to Leverage Biomarker Discovery for Cancer Treatment
Fatemeh Khatami, Nima Rezaei
Interdisciplinary cancer research (2025)
Closed Access
Fatemeh Khatami, Nima Rezaei
Interdisciplinary cancer research (2025)
Closed Access
Inhibition of Autophagy Does Not Re-Sensitize Acute Myeloid Leukemia Cells Resistant to Cytarabine
Nienke Visser, Harm Jan Lourens, Gerwin Huls, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2337-2337
Open Access | Times Cited: 21
Nienke Visser, Harm Jan Lourens, Gerwin Huls, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 5, pp. 2337-2337
Open Access | Times Cited: 21
The Increase in the Drug Resistance of Acute Myeloid Leukemia THP-1 Cells in High-Density Cell Culture Is Associated with Inflammatory-like Activation and Anti-Apoptotic Bcl-2 Proteins
M. I. Kobyakova, Yana V. Lomovskaya, А. С. Сенотов, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7881-7881
Open Access | Times Cited: 15
M. I. Kobyakova, Yana V. Lomovskaya, А. С. Сенотов, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7881-7881
Open Access | Times Cited: 15
Comparing the value of mono- vs coculture for high-throughput compound screening in hematological malignancies
Sophie A. Herbst, Vladislav Kim, Tobias Roider, et al.
Blood Advances (2023) Vol. 7, Iss. 19, pp. 5925-5936
Open Access | Times Cited: 9
Sophie A. Herbst, Vladislav Kim, Tobias Roider, et al.
Blood Advances (2023) Vol. 7, Iss. 19, pp. 5925-5936
Open Access | Times Cited: 9
Perillaldehyde is a new ferroptosis inducer with a relevant clinical potential for acute myeloid leukemia therapy
Elena Catanzaro, Eleonora Turrini, Tessa Kerre, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113662-113662
Open Access | Times Cited: 13
Elena Catanzaro, Eleonora Turrini, Tessa Kerre, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 154, pp. 113662-113662
Open Access | Times Cited: 13
Isolation, Maintenance and Expansion of Adult Hematopoietic Stem/Progenitor Cells and Leukemic Stem Cells
Isabella Maria Mayer, Andrea Hoelbl‐Kovacic, Veronika Sexl, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1723-1723
Open Access | Times Cited: 11
Isabella Maria Mayer, Andrea Hoelbl‐Kovacic, Veronika Sexl, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1723-1723
Open Access | Times Cited: 11
Phosphoproteomic Characterization of Primary AML Samples and Relevance for Response Toward FLT3-inhibitors
David G. J. Cucchi, Carolien van Alphen, Sonja Zweegman, et al.
HemaSphere (2021) Vol. 5, Iss. 7, pp. e606-e606
Open Access | Times Cited: 15
David G. J. Cucchi, Carolien van Alphen, Sonja Zweegman, et al.
HemaSphere (2021) Vol. 5, Iss. 7, pp. e606-e606
Open Access | Times Cited: 15
Ex Vivo Chemosensitivity Profiling of Acute Myeloid Leukemia and Its Correlation With Clinical Response and Outcome to Chemotherapy
Yi Zhang, Min Ji, Jinyan Zhao, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 9
Yi Zhang, Min Ji, Jinyan Zhao, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 9
In Vitro and In Vivo Modeling of Normal and Leukemic Bone Marrow Niches: Cellular Senescence Contribution to Leukemia Induction and Progression
Myriam Salazar-Terreros, Jean‐Paul Vernot
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7350-7350
Open Access | Times Cited: 8
Myriam Salazar-Terreros, Jean‐Paul Vernot
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7350-7350
Open Access | Times Cited: 8
Microenvironment Matters: In Vitro 3D Bone Marrow Niches Differentially Modulate Survival, Phenotype and Drug Responses of Acute Myeloid Leukemia (AML) Cells
Hoi Lam Cheung, Yu Hin Wong, Yuk Yin Li, et al.
Biomaterials (2024) Vol. 312, pp. 122719-122719
Closed Access | Times Cited: 1
Hoi Lam Cheung, Yu Hin Wong, Yuk Yin Li, et al.
Biomaterials (2024) Vol. 312, pp. 122719-122719
Closed Access | Times Cited: 1
Bone Marrow Stromal Cells Enhance Differentiation of Acute Myeloid Leukemia Induced by Pyrimidine Synthesis Inhibitors
Tomislav Smoljo, Hrvoje Lalić, Vilma Dembitz, et al.
AJP Cell Physiology (2024) Vol. 327, Iss. 5, pp. C1202-C1218
Closed Access | Times Cited: 1
Tomislav Smoljo, Hrvoje Lalić, Vilma Dembitz, et al.
AJP Cell Physiology (2024) Vol. 327, Iss. 5, pp. C1202-C1218
Closed Access | Times Cited: 1
Ex Vivo Expansion of Phenotypic and Transcriptomic Chronic Myeloid Leukemia Stem Cells
Sweta B. Patel, Valeriya Kuznetsova, Victoria Matkins, et al.
Experimental Hematology (2022) Vol. 115, pp. 1-13
Closed Access | Times Cited: 7
Sweta B. Patel, Valeriya Kuznetsova, Victoria Matkins, et al.
Experimental Hematology (2022) Vol. 115, pp. 1-13
Closed Access | Times Cited: 7
Genomic Abnormalities as Biomarkers and Therapeutic Targets in Acute Myeloid Leukemia
Sara Ribeiro, Anna M. Eiring, Jamshid S. Khorashad
Cancers (2021) Vol. 13, Iss. 20, pp. 5055-5055
Open Access | Times Cited: 8
Sara Ribeiro, Anna M. Eiring, Jamshid S. Khorashad
Cancers (2021) Vol. 13, Iss. 20, pp. 5055-5055
Open Access | Times Cited: 8
The Molecular Subtype of Adult Acute Lymphoblastic Leukemia Samples Determines the Engraftment Site and Proliferation Kinetics in Patient-Derived Xenograft Models
Anna Richter, Catrin Roolf, Anett Sekora, et al.
Cells (2022) Vol. 11, Iss. 1, pp. 150-150
Open Access | Times Cited: 5
Anna Richter, Catrin Roolf, Anett Sekora, et al.
Cells (2022) Vol. 11, Iss. 1, pp. 150-150
Open Access | Times Cited: 5
Targeting the Proteasome in Advanced Renal Cell Carcinoma: Complexity and Limitations of Patient-Individualized Preclinical Drug Discovery
Jielin Li, Laura Pohl, Julia Schüler, et al.
Biomedicines (2021) Vol. 9, Iss. 6, pp. 627-627
Open Access | Times Cited: 7
Jielin Li, Laura Pohl, Julia Schüler, et al.
Biomedicines (2021) Vol. 9, Iss. 6, pp. 627-627
Open Access | Times Cited: 7
Comparing the value of mono- versus coculture for high-throughput compound screening in hematological malignancies
Sophie A. Herbst, Vladislav Kim, Tobias Roider, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Sophie A. Herbst, Vladislav Kim, Tobias Roider, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 3
Streptavidin-drug conjugates streamline optimization of antibody-based conditioning for hematopoietic stem cell transplantation
Aditya R. Yelamali, Ezhilarasi Chendamarai, Julie Ritchey, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Aditya R. Yelamali, Ezhilarasi Chendamarai, Julie Ritchey, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Delineating functional and molecular impact of ex vivo sample handling in precision medicine
Nona Struyf, Albin Österroos, Mattias Vesterlund, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access
Nona Struyf, Albin Österroos, Mattias Vesterlund, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access
A New Era of Functional Experimentation in Human Hematopoiesis and Leukemia Research
Thomas Köhnke, Yang Feng, Ravindra Majeti
Experimental Hematology (2024), pp. 104652-104652
Closed Access
Thomas Köhnke, Yang Feng, Ravindra Majeti
Experimental Hematology (2024), pp. 104652-104652
Closed Access
A Combinatorial Functional Precision Medicine Platform for Rapid Therapeutic Response Prediction in AML
Noor Rashidha Binte Meera Sahib, Jameelah Sheik Mohamed, Masturah Bte Mohd Abdul Rashid, et al.
Cancer Medicine (2024) Vol. 13, Iss. 22
Open Access
Noor Rashidha Binte Meera Sahib, Jameelah Sheik Mohamed, Masturah Bte Mohd Abdul Rashid, et al.
Cancer Medicine (2024) Vol. 13, Iss. 22
Open Access
